Advansource Biomaterials Corpora (ASNB) 0.0413 $ASNB
Global Biocompatible Materials Industry
PR Newswire - Tue Sep 16, 3:55PM CDT
This report analyzes the worldwide markets for Biocompatible Materials in US$ Million by the following Product Segments: Polymeric Materials, Metallic Materials, Natural Materials, and Other Materials. The report provides separate comprehensive analytics for the US, Canada, Japan, Europe, Asia-Pacific, and Rest of World. Annual estimates and forecasts are provided for the period 2013 through 2020. Also, a seven-year historic analysis is provided for these markets. Market data and analytics are derived from primary and secondary research. Company profiles are primarily based on public domain information including company URLs. The report profiles 59 companies including many key and niche players such as -
Biomaterials Market for Implantable Devices Report - Global Industry Analysis 2013 - 2019
M2 - Wed Aug 27, 4:11AM CDT
Research and Markets (http://www.researchandmarkets.com/research/gg3kfp/biomaterials) has announced the addition of the "Biomaterials Market for Implantable Devices - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 - 2019" report to their offering. The global biomaterials market was valued at USD 25,277.8 million in 2012 and is expected to reach USD 33,600 million in 2019, growing at a CAGR of 4.1% during the forecast period 2013 to 2019 The biomaterials market comprises of material types such as metals, polymers, ceramics and materials derived from natural resources. Metals constituted the largest segment in the overall biomaterials market with a revenue share of more than 50% in the global biomaterials market. Major metals used in medical applications are alloys of titanium, nickel, chromium, nanosilver, stainless steel and aluminum. However, during the forecast period 2013 to 2019, polymers are expected to register fastest growth amongst all segments mainly because of increasing applications of these biomaterials and several advantages over metals which include flexibility, elasticity, bioinertness, biocompatibility, and longevity. The usage of polymers such as polytetrafluoroethylene (PTFE) and polyurethanes has become popular for synthetic vascular grafts, while the mainstream usage of polymers in ophthalmology is expected to increase with rising incidences of ophthalmic disorders and constant demand from aging population. In 2012, North America held the majority share in the global biomaterials market followed by Europe. These two regions together account for more than 80% of global biomaterials market and are expected to retain their position throughout the forecast period 2013 to 2019. Large number of medical implant procedures carried out in the developed nations such as the U.S., Canada, U.K., Germany, and France has been the major driver for growth of biomaterials market in North America and Europe. In Asia-Pacific region, Japan, South Korea, Australia and New Zealand are the major markets for biomaterial due to the increasing adoption of medical implant procedures in these countries. Additionally, these countries demand advanced biomaterials compared to other small developing countries in the region. However, biomaterial manufacturers view emerging countries such as China, India and Malaysia as lucrative markets due to underserved medical implants market, large patient base and high population in these nations. In Rest of the World (RoW), countries such as Brazil and South Africa are the prominent markets for biomaterials where noteworthy growth is expected in the coming years. The global biomaterials market for implantable devices is segmented as follows: Biomaterials Market, by Material Type - Metals - Polymers - Ceramics - Natural Key Topics Covered: Chapter 1 Introduction Chapter 2 Executive Summary Chapter 3 Global Biomaterials Market for Implantable Devices, Market Overview Chapter 4 Global Biomaterials Market for Implantable Devices, by Material type Chapter 5 Global Biomaterials Market for Implantable Devices, by Geography Chapter 6 Recommendations Chapter 7 Company Profiles - AdvanSource Biomaterials Corporation - Biomet, Inc. - Celanese Corporation - Ceradyne, Inc. - Collagen Matrix, Inc. - Corbion Purac - DuPont - Evonik Industries AG - Royal DSM - Invibio, Inc - Ulbrich Stainless Steel & Special Metals, Inc. For more information visit http://www.researchandmarkets.com/research/gg...omaterials
Biomaterials Market for Implantable Devices Report 2014: Metals, Polymers, Ceramics and Natural Analysis
M2 - Tue Jul 22, 3:50AM CDT
Research and Markets (http://www.researchandmarkets.com/research/nqrtf2/biomaterials) has announced the addition of the "Biomaterials Market for Implantable Devices - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 - 2019" report to their offering. The global biomaterials market was valued at USD 25,277.8 million in 2012 and is expected to reach USD 33,600 million in 2019, growing at a CAGR of 4.1% during the forecast period 2013 to 2019 The biomaterials market has been extensively analyzed on the basis of material types, their use in various healthcare applications, success rate and geographical reach. Material type segment includes metals, polymers, ceramics and biomaterials derived from natural origin. Each material type is further segmented into various healthcare applications namely, cardiology, orthopedics, dental, ophthalmology and others which include urology, neurology and gasteroenterology. Geographically, the market is analyzed for four major regions, namely North America, Europe, Asia and Rest of the World (RoW). Each of the segments have been analyzed on the basis of their current and future market size for the period 2011 to 2019, in terms of revenue generation in USD million, considering 2011 and 2012 as the base years. The compounded annual growth rate (%CAGR) for each market segment has been provided for the forecast period 2013 to 2019 along with the estimations of market size. A competitive landscape, mapping all the market players is provided in this report. The players profiled in this report include AdvanSource Biomaterials Corporation, Biomet, Inc., Celanese Corporation, Ceradyne, Inc., Collagen Matrix, Inc., DuPont, Evonik Industries AG, Corbion Purac, Ulbrich Stainless Steel & Special Metals, Inc., Royal DSM and Invibio, Inc. Each of these market players are profiled in this report considering parameters such as company overview, financial overview, business strategies, product portfolio and recent developments. Key Topics Covered: Chapter 1 Introduction Chapter 2 Executive Summary Chapter 3 Global Biomaterials Market for Implantable Devices, Market Overview Chapter 4 Global Biomaterials Market for Implantable Devices, by Material type Chapter 5 Global Biomaterials Market for Implantable Devices, by Geography Chapter 6 Recommendations Chapter 7 Company Profiles - AdvanSource Biomaterials Corporation - Biomet, Inc. - Celanese Corporation - Ceradyne, Inc. - Collagen Matrix, Inc. - Corbion Purac - DuPont (E. I. DU PONT DE NEMOURS AND COMPANY) - Evonik Industries AG - Invibio, Inc. - Orthofix Holdings, Inc. - Royal DSM - Ulbrich Stainless Steels & Special Metals, Inc. For more information visit http://www.researchandmarkets.com/research/nq...omaterials
Suburban Minerals Publishes New Website and Social Media Pages
Marketwire - Thu Feb 13, 7:15AM CST
Suburban Minerals Corp. (OTC Pink: SUBB) announced today the publishing of a new website, a Facebook page and a Twitter page as well.
Global Biomaterials Market 2012-2016: High R&D Costs Could Pose a Challenge to the Growth of the Market
M2 - Wed Feb 05, 10:58AM CST
Research and Markets (http://www.researchandmarkets.com/research/kl58bq/global) has announced the addition of the "Global Biomaterials Market 2012-2016" report to their offering. The analysts forecast the Global Biomaterials market to grow at a CAGR of 14.85 percent over the period 2012-2016. One of the key factors contributing to this market growth is the increasing aging population. The Global Biomaterials market has also been witnessing the emergence of innovative biomaterial products. However, high R&D costs could pose a challenge to the growth of this market. The key vendors dominating this space include Biomet Inc., Evonik Industries AG, Exactech Inc., and Wright Medical Group Inc. The other vendors mentioned in this report are 3DM Inc., AdvanSource Biomaterials Corp., Allergan Inc., Alphatec Spine Inc., Amedica Corp., Angiotech Pharmaceuticals Inc., Basf SE, Bayer AG, Berkeley Advanced Biomaterials Inc., Biocomposites Ltd., BioSyntech Inc., Cam Bioceramics BV, Carpenter Technology Corp., Ceradyne Inc., Ceramtec Collagen Matrix Inc., CollPlant Holdings Ltd., Covalon Technologies Ltd., CryoLife Inc., Dentsply International Inc., Depuy Orthopaedics Inc., Dsm Biomedical Inc., ETEX Corp., Heraeus Medical Components Inc., Hycail Finland OY, Integra LifeSciences Holdings Corp., Invibio Ltd., Kyocera Corp., Landec Corp., Materion Corp., Medtronic Inc., Morgan Technical Ceramics, Orthovita Inc., Osteotech Inc., Purac Biomaterials, RTI Biologics Inc., Sigma-Aldrich Corp., Starch Medical Inc., Stryker Corp., Ticona GmbH, Ulbrich Stainless Steels & Special Metals Inc., and Zimmer Holdings Inc. Commenting on the report, an analyst from the team said: There has been steady innovation in the Global Biomaterials market with several players increasing R&D expenditure every year. For instance, the use of carbon fiber in conjunction with biomaterials for the manufacture of composite materials is being explored. While innovation is imperative in an industry such as this where competition is rampant, the need for novel solutions to cater to patient needs in the Medical industry is also expected to lead to innovation in the market. Biomaterials were traditionally used for repair and replacement of body tissues. However, there has been an increasing focus on the provision of biomaterials for self-healing in patients. Thus, the Global Biomaterials market is expected to witness innovation. For more information visit http://www.researchandmarkets.com/research/kl58bq/global About Research and Markets Research and Markets is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
AdvanSource Biomaterials Completes $100,000 Short-Term Financing with Shareholders and Management
Business Wire - Tue Aug 27, 11:04AM CDT
AdvanSource Biomaterials Corporation (OTC Markets OTCQB: ASNB), a leading developer of advanced polymer materials for a broad range of medical devices, today announced the closing of a short-term debt financing transaction on August 22, 2013. The Company entered into Promissory Notes in the aggregate principal amount of $100,000 (the "Notes"
with three long-standing shareholders and the Company's chief executive officer and chief financial officer (the "Investors" . The Notes have a six-month term and bear interest at the rate of 1.75% per month. In lieu of cash payment of interest, the Investors chose to receive Warrants exercisable into an aggregate 435,000 shares of the Company's common stock. The Warrants have a one-year term and are exercisable at a 150% premium over the closing price of the Company's common stock as of August 21, 2013, or $0.075 per share. The Notes are secured by accounts receivable from undisclosed customers. Other than legal fees of approximately $5,000, the Company paid no other transaction costs.
Global Biocompatible Materials Industry
PR Newswire - Tue Sep 16, 3:55PM CDT
This report analyzes the worldwide markets for Biocompatible Materials in US$ Million by the following Product Segments: Polymeric Materials, Metallic Materials, Natural Materials, and Other Materials. The report provides separate comprehensive analytics for the US, Canada, Japan, Europe, Asia-Pacific, and Rest of World. Annual estimates and forecasts are provided for the period 2013 through 2020. Also, a seven-year historic analysis is provided for these markets. Market data and analytics are derived from primary and secondary research. Company profiles are primarily based on public domain information including company URLs. The report profiles 59 companies including many key and niche players such as -
Biomaterials Market for Implantable Devices Report - Global Industry Analysis 2013 - 2019
M2 - Wed Aug 27, 4:11AM CDT
Research and Markets (http://www.researchandmarkets.com/research/gg3kfp/biomaterials) has announced the addition of the "Biomaterials Market for Implantable Devices - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 - 2019" report to their offering. The global biomaterials market was valued at USD 25,277.8 million in 2012 and is expected to reach USD 33,600 million in 2019, growing at a CAGR of 4.1% during the forecast period 2013 to 2019 The biomaterials market comprises of material types such as metals, polymers, ceramics and materials derived from natural resources. Metals constituted the largest segment in the overall biomaterials market with a revenue share of more than 50% in the global biomaterials market. Major metals used in medical applications are alloys of titanium, nickel, chromium, nanosilver, stainless steel and aluminum. However, during the forecast period 2013 to 2019, polymers are expected to register fastest growth amongst all segments mainly because of increasing applications of these biomaterials and several advantages over metals which include flexibility, elasticity, bioinertness, biocompatibility, and longevity. The usage of polymers such as polytetrafluoroethylene (PTFE) and polyurethanes has become popular for synthetic vascular grafts, while the mainstream usage of polymers in ophthalmology is expected to increase with rising incidences of ophthalmic disorders and constant demand from aging population. In 2012, North America held the majority share in the global biomaterials market followed by Europe. These two regions together account for more than 80% of global biomaterials market and are expected to retain their position throughout the forecast period 2013 to 2019. Large number of medical implant procedures carried out in the developed nations such as the U.S., Canada, U.K., Germany, and France has been the major driver for growth of biomaterials market in North America and Europe. In Asia-Pacific region, Japan, South Korea, Australia and New Zealand are the major markets for biomaterial due to the increasing adoption of medical implant procedures in these countries. Additionally, these countries demand advanced biomaterials compared to other small developing countries in the region. However, biomaterial manufacturers view emerging countries such as China, India and Malaysia as lucrative markets due to underserved medical implants market, large patient base and high population in these nations. In Rest of the World (RoW), countries such as Brazil and South Africa are the prominent markets for biomaterials where noteworthy growth is expected in the coming years. The global biomaterials market for implantable devices is segmented as follows: Biomaterials Market, by Material Type - Metals - Polymers - Ceramics - Natural Key Topics Covered: Chapter 1 Introduction Chapter 2 Executive Summary Chapter 3 Global Biomaterials Market for Implantable Devices, Market Overview Chapter 4 Global Biomaterials Market for Implantable Devices, by Material type Chapter 5 Global Biomaterials Market for Implantable Devices, by Geography Chapter 6 Recommendations Chapter 7 Company Profiles - AdvanSource Biomaterials Corporation - Biomet, Inc. - Celanese Corporation - Ceradyne, Inc. - Collagen Matrix, Inc. - Corbion Purac - DuPont - Evonik Industries AG - Royal DSM - Invibio, Inc - Ulbrich Stainless Steel & Special Metals, Inc. For more information visit http://www.researchandmarkets.com/research/gg...omaterials
Biomaterials Market for Implantable Devices Report 2014: Metals, Polymers, Ceramics and Natural Analysis
M2 - Tue Jul 22, 3:50AM CDT
Research and Markets (http://www.researchandmarkets.com/research/nqrtf2/biomaterials) has announced the addition of the "Biomaterials Market for Implantable Devices - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 - 2019" report to their offering. The global biomaterials market was valued at USD 25,277.8 million in 2012 and is expected to reach USD 33,600 million in 2019, growing at a CAGR of 4.1% during the forecast period 2013 to 2019 The biomaterials market has been extensively analyzed on the basis of material types, their use in various healthcare applications, success rate and geographical reach. Material type segment includes metals, polymers, ceramics and biomaterials derived from natural origin. Each material type is further segmented into various healthcare applications namely, cardiology, orthopedics, dental, ophthalmology and others which include urology, neurology and gasteroenterology. Geographically, the market is analyzed for four major regions, namely North America, Europe, Asia and Rest of the World (RoW). Each of the segments have been analyzed on the basis of their current and future market size for the period 2011 to 2019, in terms of revenue generation in USD million, considering 2011 and 2012 as the base years. The compounded annual growth rate (%CAGR) for each market segment has been provided for the forecast period 2013 to 2019 along with the estimations of market size. A competitive landscape, mapping all the market players is provided in this report. The players profiled in this report include AdvanSource Biomaterials Corporation, Biomet, Inc., Celanese Corporation, Ceradyne, Inc., Collagen Matrix, Inc., DuPont, Evonik Industries AG, Corbion Purac, Ulbrich Stainless Steel & Special Metals, Inc., Royal DSM and Invibio, Inc. Each of these market players are profiled in this report considering parameters such as company overview, financial overview, business strategies, product portfolio and recent developments. Key Topics Covered: Chapter 1 Introduction Chapter 2 Executive Summary Chapter 3 Global Biomaterials Market for Implantable Devices, Market Overview Chapter 4 Global Biomaterials Market for Implantable Devices, by Material type Chapter 5 Global Biomaterials Market for Implantable Devices, by Geography Chapter 6 Recommendations Chapter 7 Company Profiles - AdvanSource Biomaterials Corporation - Biomet, Inc. - Celanese Corporation - Ceradyne, Inc. - Collagen Matrix, Inc. - Corbion Purac - DuPont (E. I. DU PONT DE NEMOURS AND COMPANY) - Evonik Industries AG - Invibio, Inc. - Orthofix Holdings, Inc. - Royal DSM - Ulbrich Stainless Steels & Special Metals, Inc. For more information visit http://www.researchandmarkets.com/research/nq...omaterials
Suburban Minerals Publishes New Website and Social Media Pages
Marketwire - Thu Feb 13, 7:15AM CST
Suburban Minerals Corp. (OTC Pink: SUBB) announced today the publishing of a new website, a Facebook page and a Twitter page as well.
Global Biomaterials Market 2012-2016: High R&D Costs Could Pose a Challenge to the Growth of the Market
M2 - Wed Feb 05, 10:58AM CST
Research and Markets (http://www.researchandmarkets.com/research/kl58bq/global) has announced the addition of the "Global Biomaterials Market 2012-2016" report to their offering. The analysts forecast the Global Biomaterials market to grow at a CAGR of 14.85 percent over the period 2012-2016. One of the key factors contributing to this market growth is the increasing aging population. The Global Biomaterials market has also been witnessing the emergence of innovative biomaterial products. However, high R&D costs could pose a challenge to the growth of this market. The key vendors dominating this space include Biomet Inc., Evonik Industries AG, Exactech Inc., and Wright Medical Group Inc. The other vendors mentioned in this report are 3DM Inc., AdvanSource Biomaterials Corp., Allergan Inc., Alphatec Spine Inc., Amedica Corp., Angiotech Pharmaceuticals Inc., Basf SE, Bayer AG, Berkeley Advanced Biomaterials Inc., Biocomposites Ltd., BioSyntech Inc., Cam Bioceramics BV, Carpenter Technology Corp., Ceradyne Inc., Ceramtec Collagen Matrix Inc., CollPlant Holdings Ltd., Covalon Technologies Ltd., CryoLife Inc., Dentsply International Inc., Depuy Orthopaedics Inc., Dsm Biomedical Inc., ETEX Corp., Heraeus Medical Components Inc., Hycail Finland OY, Integra LifeSciences Holdings Corp., Invibio Ltd., Kyocera Corp., Landec Corp., Materion Corp., Medtronic Inc., Morgan Technical Ceramics, Orthovita Inc., Osteotech Inc., Purac Biomaterials, RTI Biologics Inc., Sigma-Aldrich Corp., Starch Medical Inc., Stryker Corp., Ticona GmbH, Ulbrich Stainless Steels & Special Metals Inc., and Zimmer Holdings Inc. Commenting on the report, an analyst from the team said: There has been steady innovation in the Global Biomaterials market with several players increasing R&D expenditure every year. For instance, the use of carbon fiber in conjunction with biomaterials for the manufacture of composite materials is being explored. While innovation is imperative in an industry such as this where competition is rampant, the need for novel solutions to cater to patient needs in the Medical industry is also expected to lead to innovation in the market. Biomaterials were traditionally used for repair and replacement of body tissues. However, there has been an increasing focus on the provision of biomaterials for self-healing in patients. Thus, the Global Biomaterials market is expected to witness innovation. For more information visit http://www.researchandmarkets.com/research/kl58bq/global About Research and Markets Research and Markets is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
AdvanSource Biomaterials Completes $100,000 Short-Term Financing with Shareholders and Management
Business Wire - Tue Aug 27, 11:04AM CDT
AdvanSource Biomaterials Corporation (OTC Markets OTCQB: ASNB), a leading developer of advanced polymer materials for a broad range of medical devices, today announced the closing of a short-term debt financing transaction on August 22, 2013. The Company entered into Promissory Notes in the aggregate principal amount of $100,000 (the "Notes"
with three long-standing shareholders and the Company's chief executive officer and chief financial officer (the "Investors" . The Notes have a six-month term and bear interest at the rate of 1.75% per month. In lieu of cash payment of interest, the Investors chose to receive Warrants exercisable into an aggregate 435,000 shares of the Company's common stock. The Warrants have a one-year term and are exercisable at a 150% premium over the closing price of the Company's common stock as of August 21, 2013, or $0.075 per share. The Notes are secured by accounts receivable from undisclosed customers. Other than legal fees of approximately $5,000, the Company paid no other transaction costs. 
